Wardlow Graham 4

4 · LUXFER HOLDINGS PLC · Filed May 22, 2025

Insider Transaction Report

Form 4

Period: 2025-05-20

LUXFER HOLDINGS PLCLXFR

Wardlow Graham

See Remarks

Transactions

Exercise/Conversion
Ordinary Shares
2025-05-20+1,128→ 31,064 total
Exercise/Conversion
Ordinary Shares
2025-05-20+1,885→ 34,199 total
Exercise/Conversion
Ordinary Shares
2025-05-20+928→ 29,936 total
Exercise/Conversion
Ordinary Shares
2025-05-20+1,250→ 32,314 total
Exercise/Conversion
Ordinary Shares
2025-05-20+2,304→ 37,783 total
Exercise/Conversion
Ordinary Shares
2025-05-20+900→ 38,683 total
Sale
Ordinary Shares
2025-05-20$11.95/sh−4,874$58,244→ 33,809 total
Exercise/Conversion
Stock Options (Right to Buy)
2025-05-20$11.95/sh−928$11,090→ 0 total
Exp: 2027-03-15→ Ordinary Shares (928 underlying)
Exercise/Conversion
Ordinary Shares
2025-05-20+1,280→ 35,479 total
Exercise/Conversion
Stock Options (Right to Buy)
2025-05-20$11.95/sh−1,128$13,480→ 1,000 total
Exp: 2028-03-14→ Ordinary Shares (1,128 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2025-05-20$11.95/sh−1,250$14,938→ 2,300 total
Exp: 2029-03-20→ Ordinary Shares (1,250 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2025-05-20$11.95/sh−1,885$22,526→ 5,430 total
Exp: 2030-03-18→ Ordinary Shares (1,885 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2025-05-20$11.95/sh−1,280$15,296→ 0 total
Exp: 2027-03-15→ Ordinary Shares (1,280 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2025-05-20$11.95/sh−2,304$27,533→ 0 total
Exp: 2027-03-14→ Ordinary Shares (2,304 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2025-05-20$11.95/sh−900$10,755→ 0 total
Exp: 2027-03-14→ Ordinary Shares (900 underlying)

Holdings

Ordinary Shares
(indirect: By Spouse)
7,520

Footnotes (8)

[F1]1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
[F2]Represents the exercise of time-based Stock Options awarded on March 15, 2021. The subject Stock Options vested and were exercisable as of March 15, 2025.
[F3]Represents the exercise of time-based Stock Options awarded on March 14, 2022. The subject Stock Options vested and were exercisable as of March 14, 2025. The remaining Stock Options vest and become exercisable on March 14, 2026.
[F4]Represents the exercise of time-based Stock Options awarded on March 20, 2023. The subject Stock Options vested and were exercisable as of March 20, 2025. The remaining Stock Options vest in two equal annual installments beginning on March 20, 2026
[F5]Represents the exercise of time-based Stock Options awarded on March 18, 2024. The subject Stock Options vested and were exercisable as of March 18, 2025. The remaining Stock Options vest in three equal annual installments beginning on March 18, 2026.
[F6]Represents the grant of performance-based Stock Options (at 200% target) upon the achievement of an adjusted diluted EPS performance metric for the performance period ended December 31, 2021. One-third of the performance-based Stock Options, being 1,280 Stock Options, vested on March 15, 2023., March 15, 2024 and March15, 2025.
[F7]Represents the grant and full vesting of performance-based Stock Options (at 96% target) awarded on March 14, 2022. 100% of the performance-based Stock Options vested on March 14, 2025 upon the achievement of Earnings Per Share (EPS) Growth goals for the three-year performance period ended December 31, 2024.
[F8]Represents the grant and full vesting of performance-based Stock Options (at 25% target) awarded on March 14, 2022. 100% of the performance-based Stock Options vested on March 14, 2025 upon the achievement of Total Shareholder Return (TSR) goals for the three-year performance period ended December 31, 2024.

Documents

1 file

4
wk-form4_1747908519.xmlPrimary
FORM 4